Orthopaedic Institute for Children’s Research May Lead to Treatments for Patients with Rare Bone Disorders

Breakthrough research being funded by the Orthopaedic Institute for Children (OIC) is creating new hope for children afflicted with a rare genetic disorder that turns muscle, tendons and ligaments into bone, thus constraining movement and ultimately leading to loss of mobility. For those afflicted with this deadly disease, fibrodysplasia ossificans progressiva (FOP), median age of survival is 40 years or potentially less due to delayed diagnosis, trauma and infections.

Karen Lyons, Ph.D. stated:

FOP is the result of a gene mutation that causes non-bone forming cells to transform into bone-producing cells; as a result, bone forms in locations where it should notOur study showed that any therapy that inhibits the activity of the mutated form of the gene would probably be well tolerated in humans.

Click here to view the full release. 

Get the Latest Genetics Investing Stock Information

Get the latest information about companies associated with Genetics Investing delivered directly to your inbox.

By selecting company or companies above, you are giving consent to receive email from those companies. And remember you can unsubscribe at any time.

Comments

Leave a Reply